MorphoSys's vision

MorphoSys is committed to develop exceptional new treatments for patients suffering from serious diseases. A leader in the field of therapeutic antibodies today, MorphoSys is driven by the ambition of creating the most valuable pipeline of biopharmaceuticals in the biotechnology industry.

Presentations

06/20/2018
JMP Securities Life Sciences Conference
06/06/2018
dbAccess Berlin
Berlin, Germany
05/21/2018
UBS Global Healthcare Conference
New York, US
05/03/2018
Q1 Call Presentation
03/13/2018
Year-End Results 2017
Planegg, Deutschland

Corporate Communications and Investor Relations
Phone: +49 89 89927 404
Fax: +49 89 89927 5404
Email Contact